Private company

R1 RCM Inc. /DE

In its 2024 annual report the company says: “R1 RCM is a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups.”4 It is headquartered in Murray, Utah.1

Last updated Oct 20, 2026.

Overview

  • IndustryServices-Management Services1
  • HeadquartersMurray, Utah1
  • Business address434 W. Ascension Way, 6Th Floor, Murray, Ut 841232
  • Filer categoryLarge accelerated filer2

See how the biggest companies compare on our leaderboards

R1 RCM is a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. Our scalable operating models complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue (“NPR”) and cash flows while driving revenue yield, reducing operating costs, and enhancing the patient experience.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

6.6%Operating margin5
0.1%Net margin5
24.8%Revenue growth, 20235
0.1%Return on equity5
0.57×Debt to equity5
$237.6MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue79¢$1.8B
  • Selling, general and admin10¢$220.0M
  • Other costs11¢$243.5M
  • Income tax1¢$17.7M
  • Profit0¢$3.3M

Out of $2.3B in revenue.5

Where each dollar of operating cash went, fiscal 2023

  • Capital spending30¢$102.5M
  • Kept or used elsewhere70¢$237.6M

Out of $340.1M of cash from operations.5

Financial statements

Revenue65$2.3B in 2023+77% since 2020
0$1.0B$2.0B$3.0B2020: $1.3B$1.3B20202021: $1.5B$1.5B2021+16%2022: $1.8B$1.8B2022+23%2023: $2.3B$2.3B2023+25%
Operating income65$147.9M in 2023+89% since 2020
-$50.0M0$50.0M$100.0M$150.0M2020: $78.1M$78.1M20202021: $136.2M$136.2M2021+74%2022: -$2.8M-$2.8M20222023: $147.9M$147.9M2023
Net income65$3.3M in 2023−97% since 2020
-$100.0M-$50.0M0$50.0M$100.0M$150.0M2020: $115.2M$115.2M20202021: $87.3M$87.3M2021−24%2022: -$63.3M-$63.3M20222023: $3.3M$3.3M2023
Fiscal year20192020202120222023
Revenue$1.3B6$1.5B5$1.8B5$2.3B5
Cost of revenue$1.0B6$1.2B5$1.4B5$1.8B5
Selling, general and admin$101.3M6$122.0M5$172.5M5$220.0M5
Operating expenses$1.3B5$1.8B5$2.1B5
Operating income$78.1M6$136.2M5-$2.8M5$147.9M5
Income before tax$117.3M5-$66.8M5$21.0M5
Income tax$1.3M6$30.0M5-$3.5M5$17.7M5
Net income$115.2M6$87.3M5-$63.3M5$3.3M5
Earnings per share$0.406-$1.905-$0.185$0.015
Earnings per share (diluted)$0.326-$1.905-$0.185$0.015
Shares (weighted, basic)266.2M shares5352.3M shares5418.6M shares5
Shares (weighted, diluted)266.2M shares5352.3M shares5454.1M shares5

Compare R1 RCM Inc. /DE with another company

Corporate structure

R1 RCM Inc. /DE sits at the top of its group. 54 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of R1 RCM Inc. /DE

  • New Mountain Investments V, L.L.C. Filed SC 13D/A on R1 RCM Inc. /DE, latest Nov 22, 2024 (11 filings since Jul 1, 2022)
  • TCP-ASC ACHI Series LLLP Filed SC 13D/A on R1 RCM Inc. /DE, latest Nov 19, 2024 (12 filings since Jun 21, 2022)
  • Jeremy Delinsky Filed SC 13D on R1 RCM Inc. /DE, latest Jun 14, 2024
  • R1 RCM Inc. /DE Murray, Utah
    • Acclara Holdings Group, Inc. Subsidiary · California, United States
    • Acclara Solutions Group, LLC Subsidiary · Illinois, United States
    • Acclara Solutions Intermediate, LLC Subsidiary · Delaware, United States
    • Acclara Solutions, LLC Subsidiary · Texas, United States
    • Acclara, LLC Subsidiary · Texas, United States
    • Acustream, LLC Subsidiary · Delaware, United States
    • Advata Inc. Subsidiary · Delaware, United States
    • Alphalytics LLC Subsidiary · Pennsylvania, United States
    • AS Buyer, Inc. Subsidiary · Delaware, United States
    • Centara Data LLC Subsidiary · Texas, United States
    • cGate Health, Inc. Subsidiary · Delaware, United States
    • Clearsight Intermediate Holdings, Inc. Subsidiary · Delaware, United States
    • Cloudmed Blocker Parent, LLC Subsidiary · Delaware, United States
    • Cloudmed Holdings 1, Inc. Subsidiary · Delaware, United States
    • Cloudmed Holdings 2, Inc. Subsidiary · Delaware, United States
    • CloudMed LLC Subsidiary · Arizona, United States
    • Cloudmed Solutions, LLC Subsidiary · Delaware, United States
    • Data Bound Solutions LLC Subsidiary · Florida, United States
    • Eligibill, LLC Subsidiary · Wisconsin, United States
    • Empire Medical Review Services, LLC Subsidiary · Wisconsin, United States
    • Flare Capital Partners Investment Company Subsidiary · Delaware, United States
    • Implementation Management Assistance, LLC Subsidiary · Pennsylvania, United States
    • Intermedix ARM, LLC Subsidiary · Delaware, United States
    • Intermedix Corporation Subsidiary · Delaware, United States
    • Intermedix Holdings, Inc. Subsidiary · Delaware, United States
    • and 28 more

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What R1 RCM Inc. /DE reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Operating-lease assets (leased space)$62.5M5 Dec 31, 2023$80.5M5 Dec 31, 2022−22.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$173.6M5 Dec 31, 2023$110.1M5 Dec 31, 2022+57.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$2.6B5 Dec 31, 2023$2.6B5 Dec 31, 2022−0.4%
Intangible assets, net (excluding goodwill)$1.3B5 Dec 31, 2023$1.5B5 Dec 31, 2022−13.5%
Finite-lived intangibles, gross$1.7B5 Dec 31, 2023$1.7B5 Dec 31, 2022−0.2%
Accumulated amortization$369.5M5 Dec 31, 2023$168.6M5 Dec 31, 2022+119.2%
Finite-lived intangibles, net$1.3B5 Dec 31, 2023$1.5B5 Dec 31, 2022−13.5%

Leadership

Who has led R1 RCM Inc. /DE, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Joseph Gerard Flanagan2022
  2. Lee Rivas2023–2024

President

  1. Lee Rivas2022
  2. John M. Sparby2023–2024

Chief financial officer

  1. Rachel Wilson2022
  2. Jennifer D. Williams2023–2024
2025
Board members and other officers (31)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • AS Buyer, Inc. Delaware3
  • Acclara Holdings Group, Inc. California3
  • Acclara Solutions Group, LLC Illinois3
  • Acclara Solutions Intermediate, LLC Delaware3
  • Acclara Solutions, LLC Texas3
  • Acclara, LLC Texas3
  • Acustream, LLC Delaware3
  • Advata Inc. Delaware3
  • Alphalytics LLC Pennsylvania3
  • Centara Data LLC Texas3
  • Clearsight Intermediate Holdings, Inc. Delaware3
  • CloudMed LLC Arizona3
  • Cloudmed Blocker Parent, LLC Delaware3
  • Cloudmed Holdings 1, Inc. Delaware3
  • Cloudmed Holdings 2, Inc. Delaware3
  • Cloudmed Solutions, LLC Delaware3
  • Data Bound Solutions LLC Florida3
  • Eligibill, LLC Wisconsin3
  • Empire Medical Review Services, LLC Wisconsin3
  • Flare Capital Partners Investment Company Delaware3
  • IRS Sirrus Group, LLC Pennsylvania3
  • Implementation Management Assistance, LLC Pennsylvania3
  • Intermedix ARM, LLC Delaware3
  • Intermedix Corporation Delaware3
All 53 listed subsidiaries
  • Intermedix Holdings, Inc. Delaware3
  • Intermedix Midco, Inc. Delaware3
  • Intermedix Office Based, LLC Delaware3
  • Intermedix Staffing, Inc. Delaware3
  • Lindy Transfer Holdings, Inc. Delaware3
  • Managed Care Revenue Consulting Group, LLC New York3
  • MediRevv, LLC Delaware3
  • Medical Consultants, Inc. Oklahoma3
  • Par8o, LLC Delaware3
  • Practice Support Resources, LLC Texas3
  • Praxis Healthcare Solutions, LLC Texas3
  • Project Links Parent, Inc. Delaware3
  • R1 RCM Blocker LLC Delaware3
  • R1 RCM Global Private Limited India3
  • R1 RCM Holdco Inc. Delaware3
  • R1 RCM India Private Limited India3
  • R1 RCM Philippines, Inc. Philippines3
  • Revint Holdings, LLC Delaware3
  • Revint Intermediate III, LLC Delaware3
  • Rover16, Inc. Delaware3
  • SCHEDULING.COM, INC. Delaware3
  • Tegria Products Group, Inc. Delaware3
  • Tegria RCM Group – US, Inc. Delaware3
  • Tegria RCM Group, Inc. Delaware3
  • Tonic Health LLC Delaware3
  • Triage Consulting Group, LLC Delaware3
  • Washington & West, LLC Maryland3
  • cGate Health, Inc. Delaware3
  • iVinci Partners, LLC Delaware3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • PROJECT ROADRUNNER PARENT INC.Feb 11, 2022 to Apr 22, 20222

Timeline

  1. Nov 19, 20248-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale39
  2. Nov 14, 20248-K Shareholder vote40
  3. Nov 5, 20248-K Results of operations41
  4. Oct 22, 20248-K Results of operations42
  5. Oct 4, 20248-K Regulation FD disclosure43
  6. Sep 16, 20248-K Other events44
  7. Aug 7, 20248-K Results of operations45
  8. Aug 1, 20248-K Entered a material agreement; Other events46
  9. May 22, 20248-K Executive or director change; Shareholder vote47
  10. May 8, 20248-K Results of operations; Regulation FD disclosure48
  11. Mar 19, 20248-K Other events49
  12. Feb 27, 20248-K Results of operations; Regulation FD disclosure50
  13. Feb 21, 2023New chief executive Lee Rivas becomes CEO10
  14. Jun 23, 2022New chief executive Joseph Gerard Flanagan becomes CEO11

Calendar

When it reported results

  1. Nov 5, 2024Reported quarterly or annual results41
  2. Oct 22, 2024Reported quarterly or annual results42
  3. Aug 7, 2024Reported quarterly or annual results45
  4. May 8, 2024Reported quarterly or annual results48
  5. Feb 27, 2024Reported quarterly or annual results50
  6. Jan 8, 2024Reported quarterly or annual results51
  7. Dec 4, 2023Reported quarterly or annual results52
  8. Nov 2, 2023Reported quarterly or annual results53

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

258 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 39 major events, 131 insider forms, 24 large holders, 51 other. The latest 20:

  1. Nov 29, 202415-12G EDGAR
  2. Nov 22, 2024SC 13D/A EDGAR
  3. Nov 22, 20244 EDGAR
  4. Nov 19, 2024POSASR EDGAR
  5. Nov 19, 2024S-8 POS EDGAR
  6. Nov 19, 2024S-8 POS EDGAR
  7. Nov 19, 2024S-8 POS EDGAR
  8. Nov 19, 2024SC 13E3/A EDGAR
  9. Nov 19, 20248-K EDGAR
  10. Nov 19, 20244 OWNERSHIP DOCUMENT EDGAR
  11. Nov 19, 2024SC 13D/A EDGAR
  12. Nov 19, 20244 EDGAR
  13. Nov 19, 20244 EDGAR
  14. Nov 19, 20244 EDGAR
  15. Nov 19, 20244 EDGAR
  16. Nov 19, 20244 EDGAR
  17. Nov 19, 20244 EDGAR
  18. Nov 19, 20244 EDGAR
  19. Nov 19, 20244 EDGAR
  20. Nov 19, 20244 EDGAR

The 258 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

23 open-market trades by officers, directors and large owners since October 2021: 1 buys and 22 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 19, 2024TI IV ACHI Holdings, LPDirectorSale30,548,388$14.28$436.2MForm 4
Mar 7, 2024SPARBY JOHN M.PresidentSale10,046$14.33$144.0KForm 4
Aug 8, 2023HENNEMAN JOHN B IIIDirectorSale50,000$17.17$858.5KForm 4
Jun 12, 2023Evans Richard B. Jr.Principal Accounting OfficerSale17,000$16.84$286.3KForm 4
Jun 9, 2023Evans Richard B. Jr.Principal Accounting OfficerSale12,000$16.69$200.3KForm 4
May 10, 2023SPARBY JOHN M.PresidentSale20,000$16.36$327.2KForm 4
Feb 21, 2023RIVAS LEEChief Executive OfficerBuy71,767$13.93$999.7KForm 4
Sep 13, 2022TowerBrook Investors, Ltd.DirectorSale15,000,000$20.43$306.4MForm 4
Aug 19, 2022SPARBY JOHN M.PresidentSale40,000$25.01$1.0MForm 4
Aug 18, 2022FLANAGAN JOSEPH GERARDDirectorSale200,000$24.98$5.0MForm 4
Aug 17, 2022FLANAGAN JOSEPH GERARDDirectorSale200,000$25.02$5.0MForm 4
Aug 16, 2022FLANAGAN JOSEPH GERARDDirectorSale200,000$25.17$5.0MForm 4
Aug 12, 2022Evans Richard B. Jr.Principal Accounting OfficerSale15,000$25.25$378.8KForm 4
Aug 11, 2022LONG GARY STEVENSee RemarksSale13,130$26.08$342.4KForm 4
Aug 11, 2022Evans Richard B. Jr.Principal Accounting OfficerSale15,000$26.02$390.3KForm 4
Aug 11, 2022SPARBY JOHN M.PresidentSale4,365$26.03$113.6KForm 4
Aug 10, 2022LONG GARY STEVENSee RemarksSale189,869$25.94$4.9MForm 4
Aug 10, 2022Evans Richard B. Jr.Principal Accounting OfficerSale10,000$25.91$259.1KForm 4
Aug 10, 2022SPARBY JOHN M.PresidentSale20,000$25.95$519.0KForm 4
Aug 9, 2022SPARBY JOHN M.PresidentSale4,691$25.83$121.2KForm 4

All 23 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How R1 RCM Inc. /DE is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARR1 RCM Inc. /DE1
  • CIK0001910851
  • Employer ID (EIN)87-43407821
  • Filer statusLarge accelerated filer1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8741 Services-Management Services1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address434 W. Ascension Way, 6Th Floor, Murray, UT 841231
  • Phone(312) 324-78201
  • Shares outstanding422,394,189 as of Nov 1, 20248
  • Public float$2.9B as of Jun 30, 20235
  • On EDGAR sinceFeb 11, 20221
  • Filings261 in all: 4 (100), 8-K (37), 3 (30), SC 13D/A (21), DEFA14A (10), 10-Q (8), SC 13E3/A (5), 144 (3)1
    All 40 form types

    CORRESP (3), S-8 (3), S-8 POS (3), SC 13D (3), UPLOAD (3), 10-K (2), 10-Q/A (2), ARS (2), DEF 14A (2), PRER14A (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 25-NSE/A (1), 4/A (1), 424B3 (1), 424B7 (1), 8-K/A (1), 8-K12B (1), CT ORDER (1), DEFM14A (1), DRS (1), EFFECT (1), FWP (1), NT 10-Q (1), POSASR (1), PREM14A (1), S-3ASR (1), S-4 (1), S-4/A (1), SC 13E3 (1), SC 13G/A (1)

  • Latest filingsAnnual report (10-K) Feb 27, 2024
    Quarterly report (10-Q) Nov 5, 2024
    Proxy statement (DEF 14A) Apr 12, 2024
    Latest 8-K (8-K) Nov 19, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
    SEC EDGAROther events
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
    SEC EDGAROther events
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56